Health Regulation

Scholar argues that Congress and FDA should treat risky clinical artificial intelligence tools as medical devices.

FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.

Several U.S. Supreme Court cases from this past term have significant implications for the provision of medical care.

As fecal microbiota transplantation gains traction in the medical world, regulators may need to step in.

Experts examine how regulatory policies disproportionately affect communities of color.

Scholars reflect on the need for stronger regulatory oversight of cosmetics in the United States.

Under a lingering Trump Administration rule, more than 18,000 regulations could vanish.

A concurring opinion leaves the standard for determining the constitutionality of abortion restrictions in doubt.

The Regulatory Review’s extensive COVID-19 global series exemplifies Penn Law’s international and cross-disciplinary strengths.

Timely and extensive interventions have facilitated Portugal’s success in addressing COVID-19.

In Brazil, a political crisis rages between federal and state governments as coronavirus cases keep rising.

The pandemic appears tailor-made for Singapore’s managerial and interventionist style of governance.